Indications & formulation #
Panic disorder in adults; seizure treatment has a separate schedule. This reference covers the selected formulation; other indications and products need their own evidence.
Dose reference #
Adult educational reference · Oral tablet · United States. The clinician selects treatment after assessment; this page does not calculate or change a prescription.
Start 0.25 mg twice daily; the usual target is 1 mg/day after three days. Some patients require more; selected panic maximum 4 mg/day.
Contraindications & important cautions #
Avoid significant hepatic disease and acute narrow-angle glaucoma. Opioids/alcohol increase respiratory depression; dependence and withdrawal can be severe.
Selected important cautions; consult the full product information for all contraindications and warnings.
Adverse effects #
Sedation, ataxia, cognitive effects, dependence and withdrawal.
Interactions #
Alcohol, opioids and other sedatives increase respiratory risk.
Monitoring #
Review sedation, functioning, respiratory vulnerability, duration and taper planning.
Special populations #
Use cautious lower dosing in older adults; review respiratory disease, renal illness and pregnancy/neonatal sedation risk.
Adult scope. Pregnancy, breastfeeding and pediatric use require the exact product’s population-specific guidance and individual assessment.
Discontinuation, restarting & counseling #
Use an individualized gradual taper. Abrupt cessation can cause withdrawal seizures.
Brands & products #
Historical catalogue observations. Prices and catalogue presence do not establish current availability or Indian approval.
Reference coverage #
Structured summary of selected adult uses, not an exhaustive monograph. Indian product authorization and local prescribing requirements have not been reconciled.
References · 1
- Clonazepam — Oral tablet — selected prescribing information · United States · Checked 2026-10-27 · Selected formulation: Oral tablet · Supports indications, dose, cautions, adverse effects, interactions, monitoring, special populations and stopping. Source sections: Indications and usage; Dosage and administration; Contraindications; warnings and precautions; Use in specific populations; patient counseling
